
A recent study reveals that <b>vitamin B12</b> can reverse developmental abnormalities in laboratory organisms carrying a genetic mutation linked to Verheij syndrome. Researchers discovered that the rare condition, which causes growth problems and developmental delays, is tied to disrupted RNA splicing processes within cells. Similar metabolic changes were identified in human patients, raising hopes that this common vitamin could inspire innovative treatments for rare genetic disorders. The findings open new possibilities for understanding cellular functions and potentially targeting complex genetic conditions in the future.
This page is a shareable card. Download our app to get the full swipe experience!